P

Assignee

MAPI PHARMA LTD

IL23 patents

Top patents by PatentIndex Score

US9200114B2Dec 1, 2015

Random pentapolymer for treatment of autoimmune diseases

MAPI PHARMA LTD8 citations83
US9006188B2Apr 14, 2015

Co-crystals of dapagliflozin

MAPI PHARMA LTD8 citations83
US8377885B2Feb 19, 2013

Depot systems comprising glatiramer or pharmacologically acceptable salt thereof

MAPI PHARMA LTD14 citations83
US11471421B2Oct 18, 2022

Process for preparing microparticles containing glatiramer acetate

MAPI PHARMA LTD2 citations71
US11026908B2Jun 8, 2021

Extended release dosage forms of pregabalin

MAPI PHARMA LTD3 citations71
US10493122B2Dec 3, 2019

Sublingual delivery of glatiramer acetate

MAPI PHARMA LTD5 citations71
US11931357B2Mar 19, 2024

Depot systems comprising Cariprazine or salts thereof

MAPI PHARMA LTD2 citations69
US11167003B2Nov 9, 2021

Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems

MAPI PHARMA LTD3 citations66
USRE50301EFeb 18, 2025

Depot systems comprising glatiramer or pharmacologically acceptable salt thereof

MAPI PHARMA LTD0 citations62
USRE49251EOct 18, 2022

Depot systems comprising glatiramer or pharmacologically acceptable salt thereof

MAPI PHARMA LTD1 citations62
US12370233B2Jul 29, 2025

Depot systems comprising glatiramer acetate

MAPI PHARMA LTD0 citations59
US12251380B2Mar 18, 2025

Depot systems comprising cariprazine or salts thereof

MAPI PHARMA LTD0 citations59
US11865213B2Jan 9, 2024

Semaglutide depot systems and use thereof

MAPI PHARMA LTD1 citations58
US12343371B2Jul 1, 2025

Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate

MAPI PHARMA LTD0 citations56
US9994522B2Jun 12, 2018

Amorphous form of apremilast

MAPI PHARMA LTD0 citations51
US9453024B2Sep 27, 2016

Polymorphs of darunavir

MAPI PHARMA LTD0 citations51
US9102592B2Aug 11, 2015

Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium

MAPI PHARMA LTD0 citations51
US9096574B2Aug 4, 2015

Polymorphs of perampanel

MAPI PHARMA LTD0 citations51
US8975244B2Mar 10, 2015

Process and intermediates for the preparation of abiraterone acetate

MAPI PHARMA LTD1 citations51
US12097292B2Sep 24, 2024

Process for preparing microparticles containing glatiramer acetate

MAPI PHARMA LTD0 citations50
US12514908B2Jan 6, 2026

Semaglutide depot systems and use thereof

MAPI PHARMA LTD0 citations48
US10111867B2Oct 30, 2018

Process and intermediates for the preparation of perampanel

MAPI PHARMA LTD0 citations41
US9617241B2Apr 11, 2017

Intermediate compounds and process for the preparation of efinaconazole

MAPI PHARMA LTD0 citations36